Skip to content

XTI Aerospace, Inc. XTIA Placement Agent Warrants Issued In Series Financing

Placement Agent Warrants Issued In Series Financing at other companies

Envoy Medical logo
Envoy MedicalCOCH
$678K+594%
CNT
Canton Strategic Holdings, Inc. Common StockCNTN
$42.25K+9.1%
Scilex Holding Company logo
Scilex Holding CompanySCLX
$0-100%
Agrify Corporation logo
Agrify CorporationRYM
$6.5K
TuHURA Biosciences, Inc. logo
TuHURA Biosciences, Inc.HURA
$110.89K
Soluna Holdings, Inc. logo
Soluna Holdings, Inc.SLNH
$328.25K

Other financials

Income statement

See full
Revenue$27.7M+5,622%
Gross profit$5.1M+1,436%
Operating income-$10.4M-26.7%
Net income-$35.3M-174%
EPS (diluted)-$1.00+73.7%

Balance sheet

See full
Cash & equivalents$15.2M+89.6%
Total debt$22.8M+14,541%
Total equity-$26.6M-291%
Total assets$78.3M+189%

Cash flow

See full
Operating cash flow-$10.5M+31.4%
CapEx$131.0K+191%
Free cash flow-$10.6M+30.8%

Valuation

See full
Market cap$69.64M+136%
Enterprise value$77.3M+970%
P/S1.4×-8.3×

Profitability

See full
Gross margin19.6%-40.5pp
Operating margin-86.1%-40.7pp
Net margin-183.4%-84.9pp
FCF margin-64.6%-31.3pp

Returns & leverage

See full
Return on equity-565.7%
Debt / equity1.1×+0.6×
Current ratio0.6×-0.4×

Where this comes from

Reported directly by XTI Aerospace, Inc. in its filing.

Tagged under the XBRL concept xtia:PlacementAgentWarrantsIssuedInSeriesFinancing.

The official record: XTI Aerospace, Inc.’s 10-K, filed April 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about XTI Aerospace, Inc.'s placement agent warrants issued in series financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XTI Aerospace, Inc.'s placement agent warrants issued in series financing?
XTI Aerospace, Inc. (XTIA) reported placement agent warrants issued in series financing of $239.25K in Q4 2025.
What does placement agent warrants issued in series financing mean?
The fair value or quantity of warrants granted to placement agents as compensation for facilitating a capital raise. This represents a form of equity-based financing cost that dilutes existing shareholders.